SCHEMBL23797441

SCHEMBL23797441

COc1ccc2ccncc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 3/20 0.42
PDE2A O00408 7/20 0.40
PDE10A Q9Y233 7/20 0.40
PDE5A O76074 1/20 0.40
PDE7A Q13946 1/20 0.40
PDE3A Q14432 1/20 0.40
MAOA P21397 2/20 0.40
MAP4K4 O95819 1/20 0.39
MINK1 Q8N4C8 1/20 0.39
TNIK Q9UKE5 1/20 0.39
CLK2 P49760 2/20 0.38
DYRK1A Q13627 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
DYRK1B Q9Y463 2/20 0.38
CLK3 P49761 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29889787 0.84 CLK1 (0.42) CLK1PDE2APDE10APDE5APDE7A
SCHEMBL30748587 0.74 KDM4E (0.61) CLK1PDE2APDE10APDE5APDE7A
SCHEMBL17496481 0.74 HTT (0.45) PDE5AMAOACYP19A1KDM4EPDGFRB
SCHEMBL16751340 0.73 PDE10A (0.46) PDE2APDE10APDE5APDE7APDE3A
SCHEMBL7513190 0.72 CYP1A2 (0.52) PDE10AMAP4K4MINK1TNIKKDM4E
SCHEMBL29392943 0.72 KDM4E (0.53) KDM4E
SCHEMBL23674958 0.72 MAP4K4 (0.42) CLK1PDE10APDE3AMAP4K4MINK1
SCHEMBL621727 0.72 KDM4E (0.53) KDM4E
SCHEMBL24394846 0.72 KDM4C (0.44) MAP4K4MINK1TNIKPDGFRBPDGFRA
SCHEMBL31269699 0.72 MAP4K4 (0.58) CLK1PDE10APDE3AMAOAMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3876928-B1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME LLC (US) 2024-10-23 EP disclosed
US-20210403479-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2021-12-30 US disclosed
US-20210403479-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2021-12-30 US disclosed
EP-3876928-A2 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION Merck Sharp & Dohme Corp. (US) 2021-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403479-A1 INHIBITORS OF HISTONE DEACETYLASE USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION HDAC1, HDAC11, HDAC3 CLK1 4168/4885PDE2A 671/4885PDE10A 2872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.